FDA Endorses Suzetrigine Pain Drug
This is a news story, published by BGR, that relates primarily to Journavx news.
Journavx news
For more Journavx news, you can click here:
more Journavx newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsBGR news
For more news from BGR, you can click here:
more news from BGRAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
new pain medication. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest opioids news, suzetrigine news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pain medicationBGR
•Health
Health
FDA approved the first new kind of pain medication in 27 years. Here’s how it works

66% Informative
The drug is called suzetrigine and will be sold under the brand name Journavx .
This new medication is a non-opioid alternative designed to control pain without the risk of addiction.
Every year , 80 million Americans receive prescriptions for pain medication, and roughly half of those are opioids.
VR Score
46
Informative language
33
Neutral language
51
Article tone
informal
Language
English
Language complexity
50
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
3
Affiliate links
no affiliate links